9 results match your criteria: "Royal Bolton Hospital NHS Trust[Affiliation]"
Gland Surg
February 2024
Guy's & St Thomas NHS Foundation Trust, London, UK.
Oncoplastic breast surgery (OPS) has become an integral part of breast cancer surgery for both breast conservation and mastectomies. In recent years, the emphasis on early detection and the advances in systemic and locoregional therapy has improved prognosis leading to an increased focus on survivorship and quality of life issues including patients' short and long-term aesthetic appearance as a key part of the surgical management. There is a significant variation across Europe in the type of specialist performing breast cancer surgery and the provision of OPS as such.
View Article and Find Full Text PDFShoulder Elbow
April 2018
Trauma and Orthopaedic Department, Royal Bolton Hospital NHS Trust, Bolton, UK.
Transfus Clin Biol
December 2011
Department of Blood Sciences, Royal Bolton Hospital NHS Trust UK, 4, Minerva Road, BL4 0JR Bolton, United Kingdom.
Blood may be transfused as whole blood or as one of its components. Because patients seldom require all of the components of whole blood, it makes sense to transfuse only that portion needed by the patient for a specific condition or disease. This treatment, known as "blood component therapy", allows several patients to benefit from one unit of donated whole blood.
View Article and Find Full Text PDFInt J Womens Health
December 2010
Department of Blood Sciences, Royal Bolton Hospital NHS Trust UK.
Transplacental or fetomaternal hemorrhage (FMH) may occur during pregnancy or at delivery and lead to immunization to the D antigen if the mother is Rh-negative and the baby is Rh-positive. This can result in hemolytic disease of the fetus and newborn (HDFN) in subsequent D-positive pregnancies. The aim of this study is to highlight the challenges associated with the effective management and prevention of Rh alloimmunization among Rh-negative women in Sub-Saharan Africa.
View Article and Find Full Text PDFIn 2008 the Organ Donation Taskforce published its recommendations for increasing organ donation in the UK by 50% over 5 years. Bolton NHS Trust has addressed the problem of low rates of organ donation by amalgamating Bereavement and Donation Services and introducing a trigger to refer automatically all potential organ donors to the regional transplant donor co-ordinators. We audited the ability of the new service to deliver the aims and recommendations of the Organ Donation Taskforce.
View Article and Find Full Text PDFAcute Med
October 2012
Royal Bolton Hospital NHS Trust, Bolton, BL4 0JR.
This patient was diagnosed as having Stevens-Johnson Syndrome. The most likely cause was the sulfasalazine, which had been started recently. This drug was stopped.
View Article and Find Full Text PDFA fifty-one-year-old man with history of treated hypertension and seronegative rheumatoid arthritis presented to hospital with a three day history of a rash affecting the whole body and general malaise. He had been commenced on sulfasalazine 2 weeks ago to control his rheumatoid arthritis, which the patient had discontinued taking three days prior to admission. On examination, he was comfortable with a temperature of 39°C and a widespread erythematous maculopapular rash.
View Article and Find Full Text PDFProstate Cancer Prostatic Dis
May 2004
Department of Urology, Royal Bolton Hospital NHS Trust, Farnworth, Bolton, Lancashire, UK.
We performed a prospective randomised double-blind study to evaluate the efficacy of Entonox (nitrous oxide) as an analgesic for trans-rectal ultrasound (TRUS) and prostate biopsy. A total of 50 patients breathed either Entonox or air during sextant prostatic biopsies all of which were performed by the same surgeon. The degree of pain experienced was recorded on a 100 mm visual analogue pain scale.
View Article and Find Full Text PDFJ Antimicrob Chemother
January 1998
The sepsis syndrome has proved to be one of the most difficult clinical situations to replicate in animal models. The outcome of sepsis in patients depends not only on the pathogens, sizes of bacterial challenge and adequacy of treatment, but also on age, host defence mechanisms and individual response to septic shock and multiple organ failure. Novel immunomodulatory agents may control endotoxaemia or bacteraemia in animal models but they have not proved effective in septic patients.
View Article and Find Full Text PDF